190 related articles for article (PubMed ID: 35062299)
1. Modulation of HIV Replication in Monocyte-Derived Macrophages (MDM) by Host Antiviral Factors Secretory Leukocyte Protease Inhibitor and Serpin Family C Member 1 Induced by Steroid Hormones.
Biswas S; Chen E; Gao Y; Lee S; Hewlett I; Devadas K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062299
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
[TBL] [Abstract][Full Text] [Related]
3. Modulation of HIV replication in monocyte derived macrophages (MDM) by steroid hormones.
Devadas K; Biswas S; Ragupathy V; Lee S; Dayton A; Hewlett I
PLoS One; 2018; 13(1):e0191916. PubMed ID: 29373606
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8.
Petersen M; Lotke R; Hopfensperger K; Victoria S; Haußmann I; Burster T; Baldauf HM; Sauter D
J Virol; 2023 Jun; 97(6):e0029423. PubMed ID: 37272794
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
Jana NK; Gray LR; Shugars DC
J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
[TBL] [Abstract][Full Text] [Related]
8. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.
Wen J; Nikitakis NG; Chaisuparat R; Greenwell-Wild T; Gliozzi M; Jin W; Adli A; Moutsopoulos N; Wu T; Warburton G; Wahl SM
Am J Pathol; 2011 Jun; 178(6):2866-78. PubMed ID: 21641406
[TBL] [Abstract][Full Text] [Related]
9. The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.
Py B; Basmaciogullari S; Bouchet J; Zarka M; Moura IC; Benhamou M; Monteiro RC; Hocini H; Madrid R; Benichou S
PLoS One; 2009; 4(3):e5006. PubMed ID: 19333378
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor modulates FcεRI-dependent but not Mrgprb2-dependent mastocyte function in psoriasis.
Kwiecinska P; Kwitniewski M; Kwiecien K; Morytko A; Majewski P; Pocalun N; Pastuszczak M; Migaczewski M; Cichy J; Grygier B
Int Immunopharmacol; 2023 Sep; 122():110631. PubMed ID: 37453153
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells.
Abbinante-Nissen JM; Simpson LG; Leikauf GD
Am J Physiol; 1993 Sep; 265(3 Pt 1):L286-92. PubMed ID: 8105697
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
Skott P; Lucht E; Ehnlund M; Björling E
Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
15. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.
Sabbatucci M; Covino DA; Purificato C; Mallano A; Federico M; Lu J; Rinaldi AO; Pellegrini M; Bona R; Michelini Z; Cara A; Vella S; Gessani S; Andreotti M; Fantuzzi L
Retrovirology; 2015 Jan; 12():4. PubMed ID: 25608886
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
Jobe O; Trinh HV; Kim J; Alsalmi W; Tovanabutra S; Ehrenberg PK; Peachman KK; Gao G; Thomas R; Kim JH; Michael NL; Alving CR; Rao VB; Rao M
J Leukoc Biol; 2016 Jun; 99(6):1089-106. PubMed ID: 26667473
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte peptidase inhibitor and lung cancer.
Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
[TBL] [Abstract][Full Text] [Related]
18. Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.
Khoury G; Ewart G; Luscombe C; Miller M; Wilkinson J
Antimicrob Agents Chemother; 2010 Feb; 54(2):835-45. PubMed ID: 19995924
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.
Fakioglu E; Wilson SS; Mesquita PM; Hazrati E; Cheshenko N; Blaho JA; Herold BC
J Virol; 2008 Oct; 82(19):9337-44. PubMed ID: 18667508
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
